Press Release

Joint Pain Injections Market: Coronavirus Impact – Key Takeaways

CDC reports that every year approximately 15 million people in the U.S. face severe joint pain because of arthritis. The rising prevalence of arthritis can increase the demand for treatments, which in turn, will propel the growth of the global joint pain injections market. The information is shared by Fortune Business Insights, in a report, titled “Joint Pain Injections Market Size, Share and Global Trend By Product (Corticosteroid Injections, Hyaluronic Acid Injections, Platelet-Rich Plasma Injections, Others (Placental Tissue Matrix Injections, etc), By Joint Type (Knee and Ankle, Hip, Shoulder and Elbow, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography Forecast till 2026.” One of the most common types of arthritis is osteoarthritis which primarily affects hands and feet. Some of the major causes associated with osteoarthritis are the rising prevalence of obesity, increasing aging population, zero physical activity, and mineral bone density loss.  Injections such as hyaluronic acid and corticosteroid are extensively used to reduce pain and inflammation in affected areas.


  • Global Joint Pain Injections Market trends, with detailed analysis on consumer trends & manufacturer trends.
  • Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
  • Key areas of investments identifying market opportunities and challenges in forecast timeframe.
  • Competitive analysis of the industry players along with the overview on strategic management.
  • Comprehensive company profiles of the major industry players.


Request a Sample Copy of the Research Report:



Leading Players operating in the Joint Pain Injections Market are:


Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:


  • Anika Therapeutics, Inc.,
  • Teva Pharmaceuticals Industries Ltd.,
  • Flexion Therapeutics Inc.,
  • Pfizer Inc.,
  • Reddy’s Laboratories Ltd.,
  • Zimmer Biomet,
  • Bioventus,
  • Ferring B.V.

Segmentation of the Global Joint Pain Injections Market

By Product

  • Corticosteroid Injections
  • Hyaluronic Acid Injections
  • Platelet-Rich Plasma Injections
  • Others (Placental Tissue Matrix Injections, etc.)

By Joint Type

  • Knee and Ankle
  • Hip
  • Shoulder and Elbow
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America (the U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

More Trending Topics From Fortune Business [email protected]

Legionella Testing Market Share

Legionella Testing Market size

Legionella Testing Market Share

Legionella Testing Market size

Legionella Testing Market Share

Legionella Testing Market size

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *